Portable Device May Improve Cardiac Testing, Decrease Hospital Stay
CINCINNATINew devices that bring the laboratory to the patients side in the emergency room could be used to speed the care of cardiac patients and improve their outcomes, say University of Cincinnati (UC) researchers.
Results of this researchled by UCs Richard Ryan, MD, and conducted at four emergency departments across the countryare published in the Aug. 4, 2008, online edition of the Annals of Emergency Medicine.
When patients visit the emergency room with chest pain, physicians typically conduct an ECG (electrocardiogram) and then test the blood for markers that could indicate heart trouble. The American Heart Association (AHA) says the results of this blood test should be available to the doctor in less than 60 minutes. The problem is that hospital laboratories often struggle to get results to the doctor in less than an hour.
UC emergency medicine researchers at Jewish Hospital in
Despite its speed, i-STAT and other similar devices are only as efficient as those using the device and acting on its results.
The emergency department is a staircase, with point-of-care testing being one big step, says Ryan, vice chairman of UCs emergency medicine department. There are ways to get things done and get them done faster. But, he adds, Real efficiencies depend on the many other steps as well.
Christopher Lindsell, PhD, a research assistant professor in UCs emergency medicine department, says that emergency medicine physicians dealing with acute coronary syndromes commonly say time is muscle.
This is not about the brand of device, this is about the physician being able to get the result of the tests faster, and make decisions about how to treat the patient faster, Lindsell adds.
For example, the
Theres no doubt that bringing the laboratory to the patients side is faster, says Lindsell, but exactly when a physician decides to order a test, and what happens between the physician getting the results and administering appropriate therapy can drastically change what happens, regardless of the testing device.
Lindsell and Ryan have been studying this whole process. The investigators watch what is going on in the emergency department and the laboratory from the moment a test ordered to when the physician actually gets the results, and they use their observations to work out what other delays there are in the system. Those delaysa difficult blood draw for examplecan then be corrected so that patient care can be as rapid and effective as possible.
Coauthors include W. Brian Gibler, MD, University of Cincinnati; Judd Hollander, MD, University of Pennsylvania; Brian ONeil, MD, and Raymond Jackson, MD, William Beaumont Hospital, Royal Oak, Mich.; Donald Schreiber, MD, Stanford University; and Robert Christenson, PhD, University of Maryland, Baltimore.
The study was sponsored by Abbott Point of Care. Authors report no financial interests with the study sponsor.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.